Pubblicazioni

M8Concomitant versus sequential Fotemustine and Bevacizumab in recurrent malignant gliomas: treatment response and survival outcomes in a retrospective analysis

2017 - ANNALS OF ONCOLOGY

Prelaj, A; Rebuzzi, S E; GirÃ²n BerrÃ¬os, J R; Pecorari, S; Fusto, C; Ferrara, C; Salvati, M; Tomao, S; Bianco, Vito

Prognostic value of systemic inflammatory biomarkers in patients with mCRPC treated with abiraterone in pre-docetaxel setting

2017 - ANNALS OF ONCOLOGY

Ratta, R.; Verzoni, E.; Pantano, F.; Grassi, P.; De Lisi, D.; Onorato, A.; Prisciandaro, M.; Montone, R.; de Braud, F.; Santini, D.; Procopio, G.

Comparative effects of Folfirinox and Gemcitabine/nab-paclitaxel as first and second line chemotherapy for metastatic pancreatic cancer: single choice or sequence

2017 - ANNALS OF ONCOLOGY

Caponnetto, S.; Gelibter, A.; Mosillo, C.; Magri, V.; Scagnoli, S.; Pomati, G.; Piesco, G.; Verkhovskaya, S.; Pisegna, S.; Sirgiovanni, G.; Napoli, V.; Buscicchio, D.; Iannantuono, G. M.; Marinelli, D.; Mammone, G.; Pannunzio, S.; Nicolo', E.; Stefani, A.; Astorino, V.; Mancini, M.; Cortesi, E.

Adjuvant treatment in elderly cancer patients: a multicenter real-life experience

2017 - ANNALS OF ONCOLOGY

Bassanelli, M.; Ceribelli, A.; Giannarelli, D.; Giacinti, S.; Viterbo, A.; Siringo, M.; Poti, G.; Roberto, M.; Macrini, S.; Falcone, R.; Giuli, A.; Di Pietro, F. R.; Aschelter, A. M.; Marchetti, P.